|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision (reversal of provision) for credit losses | |||||
| Net (gain) loss on sales of investment debt and equity securities | |||||
| Net unrealized loss (gain) on equity securities | |||||
| Net gain on sale of loans | |||||
| Proceeds from sales of residential mortgages held-for-sale | |||||
| Origination of residential mortgages held-for-sale | |||||
| Increase on bank-owned life insurance | |||||
| Stock-based compensation expense | |||||
| Amortization of deferred costs on subordinated debt | |||||
| Deferred income tax provision (benefit) | |||||
| Net increase (decrease) in income taxes payable | |||||
| Net decrease (increase) in accrued interest receivable | |||||
| Fair value remeasurements on interest rate swap | |||||
| Amortization of mortgage servicing rights and change in valuation allowance | |||||
| Net amortization of premiums and discounts on investment securities | |||||
| Net (decrease) increase in accrued interest payable | |||||
| Operating lease payments | |||||
| Increase in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Proceeds from payments, maturities and calls of investment debt securities available-for-sale | |||||
| Proceeds from the sale of investment securities available-for-sale | |||||
| Purchases of investment securities available-for-sale | |||||
| Proceeds from the sale of equity securities | |||||
| Purchases of equity securities | |||||
| Proceeds from redemption of investment in restricted bank stock | |||||
| Purchase of restricted bank stock | |||||
| Net increase in loans | |||||
| Net purchases of premises and equipment | |||||
| Redemption of Bank Owned Life Insurance investment | |||||
| Net cash (used) provided in investing activities | |||||
| Financing Activities | |||||
| Net increase (decrease) in non-interest bearing deposits | |||||
| Net increase in interest-bearing deposits | |||||
| Net increase (decrease) in short-term borrowings | |||||
| Issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Issuance of subordinated debt | |||||
| Cash dividends paid, net of reinvestment | |||||
| Proceeds from issuance of common stock | |||||
| Net cash provided by financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Cash Flow Disclosures | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds received | |||||
| Federal income taxes paid, net of refunds received | |||||
| State income taxes paid, net of refunds received | |||||
| Total income taxes paid, net of refunds received | |||||
| Non-cash transactions: | |||||
| Cumulative change in accounting principal | |||||
| Trade-date settlements for matured securities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
Loading...